New Zealand – Healthcare, Regulatory and Reimbursement Landscape

GlobalData, the industry analysis specialist, has released its latest report, “New Zealand – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in New Zealand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The New Zealand pharmaceutical market is one of the major pharmaceutical markets of the Southwestern Pacific region that increased from $0.65B in 2011 at a Compound Annual Growth Rate (CAGR) of 7% to $0.98B in 2019. It is forecast to reach about $1.47B in 2025. The growth in the market is attributed to high levels of research and development, growing elderly population, and a strong clinical trial environment. However, an underfunded medicine budget and increased timelines for medicine funding pose barriers to the pharmaceutical industry. The New Zealand medical devices market was estimated to be $0.92B in 2015, which increased at a CAGR of 6% to reach $1.24B in 2020. The market is expected to grow at a CAGR of 5% from to reach $1.59B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, GSK, Pfizer, AstraZeneca, and Blis Technologies.

Profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Zimmer Biomet, Alcon, Olympus, and Fisher & Paykel Healthcare.

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in New Zealand healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving New Zealand healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact New Zealand healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents

1.1List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about New Zealand Healthcare Market

2.3 Key Highlights: Healthcare Startups in New Zealand

2.4 Key Events: New Zealand Pharmaceutical News, 2015-2021

2.5 Key Events: New Zealand Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, New Zealand, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Five-Year Action Plan of Ministry of Health, New Zealand, 2015 – 2020

3.3 Pharmaceutical Market – Exports

3.4 Pharmaceutical Market – Imports

3.5 Pharmaceutical Market – Supply Channels, New Zealand

3.6 Pharmaceutical Market – Market Segments

3.7 Major Therapeutic Areas, New Zealand

3.8 COVID-19 Epidemiology, New Zealand

3.9 COVID-19 Impact and Developments, New Zealand

3.10 COVID-19 Clinical Trials Landscape, New Zealand

3.11 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, New Zealand, 2019-2021

6.2 Deal Analysis: Medical Device Market, New Zealand, 2019-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, New Zealand

7.2 HealthTech Deals Landscape, New Zealand

7.3 Adoption of Technology in Healthcare, New Zealand

7.4 Key HealthTech Deals, New Zealand

7.5 Digital Health Regulations, New Zealand

7.6 HealthTech Landscape: Benefits and Risks, New Zealand

8. Market Access

8.1 Overview of Healthcare System, New Zealand

8.2 Drug Reimbursement Process, New Zealand

8.3 Overview of Insurance Providers, New Zealand

8.4 Out-of-Pocket Co-Payments and Safety Nets, New Zealand

8.5 Out-of-Pocket Spending, New Zealand

8.6 Pricing Policies, New Zealand

8.7 Regulatory Landscape, New Zealand

8.7.1 Overview of Regulatory Agencies, New Zealand

8.7.2 Marketing Authorization for Pharmaceutical Products, New Zealand

8.7.3 Marketing Authorization for Generic Medicines, New Zealand

8.7.4 Marketing Authorization for Biosimilars, New Zealand

8.7.5 Marketing Authorization for Medical Devices, New Zealand

8.7.6 Import Regulations, New Zealand

8.7.7 Intellectual Property Rights, Patent, New Zealand

8.7.8 Intellectual Property Rights, Trademark, New Zealand

8.7.9 Clinical Trial Regulation Process, New Zealand

8.7.10 Pharmaceutical Clinical Trials Landscape, New Zealand

8.7.11 Medical Devices Clinical Trials Landscape, New Zealand

8.7.12 Pharmacy License Regulations, New Zealand

8.7.13 Pharmaceutical Advertisement Regulations, New Zealand

8.7.14 Labeling and Packaging Regulations, New Zealand

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, New Zealand

9.2 Healthcare Facilities, New Zealand

9.3 Healthcare Parameters, New Zealand

9.4 Life Expectancy and Immunization Rate, New Zealand

9.5 Environmental Health, New Zealand

9.6 Healthcare Personnel, New Zealand

9.7 Disease Burden, US New Zealand

9.8 Healthcare Expenditure, New Zealand

11 Trade Associations, Conferences, and Trade Fairs, New Zealand

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

List of Tables

Table 1: Approved Biosimilars, New Zealand, 2019-2020

Table 2: COVID-19 Indicators (Number of cases), New Zealand and Global, 2020-2021

Table 3: COVID-19-Related Travel Restrictions, New Zealand, 2020-2021

Table 4: Objectives of the National COVID-19-Testing Strategy (Five Parts), New Zealand, 2020

Table 5: Available COVID-19-Vaccines,New Zealand, 2020-2021

Table 6: COVID-19 Vaccine Rollout Plan, New Zealand, 2020-2021

Table 7: List of COVID-19 Clinical Trials Sponsors by Count, New Zealand, 2020-2021

Table 8: Medical Devices Market, New Zealand, Major Segments ($M), 2020

Table 9: Anesthesia & Respiratory Devices Market, New Zealand, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 10: Orthopedic Devices Market, New Zealand, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 11: General Surgery Devices Market, New Zealand, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 12: In Vitro Diagnostic Devices Market, New Zealand, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 13: Cardiovascular Devices Market, New Zealand, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 14: Typical Patient Copayments and Safety Nets, New Zealand, 2019

Table 15: NMA Fee, New Zealand, 2019

Table 16: Patent Application Fee, New Zealand, 2020

Table 17: Trademark Application Fee, New Zealand, 2020

Table 18: Clinical Trial Application Fee, New Zealand, 2019

Table 19: Conferences and Trade Fairs, New Zealand, 2021

List of Figures

Figure 1: Pharmaceutical Market, New Zealand, Revenue ($B and NZD), 2013-2020

Figure 2: Medical Device Market, New Zealand, Revenue ($B), 2015-2020

Figure 3: Healthcare Start-Ups in New Zealand, 2020

Figure 4: Country Profile, New Zealand, 2020

Figure 5: Pharmaceutical Market, New Zealand, Revenue ($B), 2011-2019

Figure 6: Pharmaceutical Market, New Zealand, Revenue Forecast ($B), 2020-2025

Figure 7: Focus Areas of Five-Year Action Plan of Ministry of Health, New Zealand, 2015-2020

Figure 8: Pharmaceutical Exports ($M), New Zealand, 2011-2020

Figure 9: Top Export Partners, New Zealand, 2020

Figure 10: Pharmaceutical Imports ($M), New Zealand, 2011-2020

Figure 11: Top Import Partners, New Zealand, 2020

Figure 12: Pharmaceutical Supply Channel, New Zealand, 2016

Figure 13: Medicine Supply Issue Management, PHARMAC, New Zealand, 2020

Figure 14: Generic Drugs Usage (% share by volume), New Zealand, 2010-2019

Figure 15: Generic Drugs Usage (% share by value), New Zealand, 2010-2019

Figure 16: OTC Market, New Zealand, Revenue ($M), 2013-2020

Figure 17: OTC Market by Drug Category, Revenue ($M), New Zealand, 2020

Figure 18: OTC Medicines Market, Major Distribution Channels ($M), New Zealand, 2020

Figure 19: Pharmaceutical Sales by Drug Category ($M), New Zealand, 2020

Figure 20: Major Therapeutic Areas by Pharmaceutical Sales ($M), New Zealand, 2017-2019

Figure 21: COVID-19 (Number of cases), New Zealand, 2020-2021

Figure 22: COVID-19 (Number of deaths), New Zealand, 2020-2021

Figure 23: COVID-19 Fiscal Stimulus Timeline, New Zealand, 2020-2021

Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, New Zealand, 2020-2021

Figure 25: Top COVID-19 Markets by Product Categories (Number of available marketed products), New Zealand, 2020-2021

Figure 26: Top COVID-19 IVD Products by Device Class (Number of available marketed products), New Zealand, 2020-2021

Figure 27: COVID-19 Clinical Trials Count by Phase, New Zealand, 2020-2021

Figure 28: COVID-19 Clinical Trials Count by Trial Status, New Zealand, 2020-2021

Figure 29: Medical Devices Market, New Zealand, Revenue ($B), 2015-2020

Figure 30: Medical Devices Market, New Zealand, Revenue Forecast ($B), 2021-2025

Figure 31: Medical Devices Market, New Zealand, Major Segments (%), 2020

Figure 32: Anesthesia & Respiratory Devices Market, New Zealand, Revenue ($M), 2015-2022

Figure 33: Anesthesia & Respiratory Devices Market, New Zealand, Market Share of Major Players (%), 2020

Figure 34: Orthopedic Devices Market, New Zealand, Revenue ($M), 2015-2022

Figure 35: Orthopedic Devices Market, New Zealand, Market Share of Major Players (%), 2020

Figure 36: General Surgery Devices Market, New Zealand, Revenue ($M), 2015-2022

Figure 37: General Surgery Devices Market, New Zealand, Market Share of Major Players (%), 2020

Figure 38: In Vitro Diagnostic Devices Market, New Zealand, Revenue ($M), 2015-2022

Figure 39: In Vitro Diagnostic Devices Market, New Zealand, Market Share of Major Players (%), 2020

Figure 40: Cardiovascular Devices Market, New Zealand, Revenue ($M), 2015-2022

Figure 41: Cardiovascular Devices Market, New Zealand, Market Share of Major Players (%), 2020

Figure 42: Diagnostic Market, New Zealand, Revenue ($M), 2015-2020

Figure 43: Diagnostic Market, New Zealand, Revenue Forecast ($M), 2021-2025

Figure 44: Medical Devices Market, New Zealand, Revenue ($B) of Major Companies, 2019

Figure 45: Deal Value and Deal Count, Pharmaceutical Market, New Zealand, 2019-2021

Figure 46: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, New Zealand, 2019-2021

Figure 47: Deal Value and Deal Count Subtypes, Pharmaceutical Market, New Zealand, 2019-2021

Figure 48: Top Therapy Areas by Deal Value, Pharmaceutical Market, New Zealand, 2019-2021

Figure 49: Mergers and Acquisitions by Quarter, Pharmaceutical Market, New Zealand, 2019-2021 (by value and by number)

Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, New Zealand, 2019-2021

Figure 51: Deal Value and Deal Count, Medical Devices Market, New Zealand, 2019-2021

Figure 52: Deal Value and Deal Count, Quarterly, Medical Devices Market, New Zealand, 2019-2021

Figure 53: Deal Value and Deal Count Subtypes, Medical Devices Market, New Zealand, 2019-2021

Figure 54: Top Equipment Sectors by Deal Value, Medical Devices Market, New Zealand, 2019-2021

Figure 55: Top Equipment Sectors by Deal Count, Medical Devices Market, New Zealand, 2019-2021

Figure 56: M&A Deals by Equipment Sector, Medical Devices Market, New Zealand, 2019-2021 (by value and by number)

Figure 57: Components of Digital Health Strategy, New Zealand, 2016-2020

Figure 58: Themes of Digital Health Strategy, New Zealand, 2018-2026

Figure 59: Digital Health Vision Focus Areas, New Zealand, 2018-2026

Figure 60: Deal Value ($M), HealthTech, New Zealand, 2019-2021

Figure 61: Deal Count (Number of Deals), HealthTech, New Zealand, 2019-2021

Figure 62: Principles for the Safe and Effective Use of Data and Analytics, New Zealand, 2018

Figure 63: Principles of Privacy Act 1993, New Zealand

Figure 64: Key Health Sector Organizations and People, New Zealand

Figure 65: Overview of Health System, New Zealand, 2020

Figure 66: PHARMAC Funding Criteria, New Zealand, 2020

Figure 67: Reimbursement Process, New Zealand, 2020

Figure 68: Private Health Insurance (% of total population), New Zealand, 2012-2019

Figure 69: Out-of-Pocket Spending (% of health spending), New Zealand, 2010-2018

Figure 70: Change in Pharmaceutical Price Index (2015 = 100), New Zealand, 2012-2020

Figure 71: Commercial Strategies Used by PHARMAC, New Zealand, 2020

Figure 72: Marketing Authorization for Pharmaceutical Products, New Zealand, 2019

Figure 73: Licensure of a Biosimilar Product, New Zealand, 2020

Figure 74: WAND Process for Medical Devices Approval, New Zealand, 2019

Figure 75: Patent Approval Process, New Zealand, 2019

Figure 76: Trademark Registration Process, New Zealand, 2019

Figure 77: Clinical Trial Approval Process, New Zealand, 2018

Figure 78: Pharmaceutical Clinical Trials Count by Trial Status, New Zealand, 2019-2021

Figure 79: Pharmaceutical Clinical Trials Count by Phase, New Zealand, 2019-2021

Figure 80: Pharmaceutical Clinical Trials Count by Indication, New Zealand, 2019-2021

Figure 81: Top Five Pharmaceutical Clinical Trials Sponsors by Count, New Zealand, 2019-2021

Figure 82: Medical Devices Clinical Trials Count by Trial Status, New Zealand, 2019-2021

Figure 83: Medical Devices Clinical Trials Count by Indication, New Zealand, 2019-2021

Figure 84: Medical Devices Clinical Trials Count by Device Category, New Zealand, 2019-2021

Figure 85: Top Five Medical Devices Clinical Trials Sponsors by Count, New Zealand, 2019-2021

Figure 86: Number of Hospitals (number), New Zealand, 2012-2019

Figure 87: Total Number of Diagnostic Equipment Units (number), New Zealand, 2012-2018

Figure 88: Number of Hospital Beds (per 1,000 Population), New Zealand, 2012-2019

Figure 89: Number of Acute Care Beds (per 1,000 Population), New Zealand, 2012-2019

Figure 90: Number of Psychiatric Care Beds (per 1,000 Population), New Zealand, 2012-2019

Figure 91: Life Expectancy at Birth (Years), New Zealand, 2012-2018

Figure 92: Immunization Rate (% of children immunized), New Zealand, 2012-2019

Figure 93: PM2.5 (µg per m3), New Zealand, 2012-2019

Figure 94: CO2 Emissions (Mt CO2), New Zealand, 2012-2019

Figure 95: Physicians (per 1,000 Population), New Zealand, 2012-2018

Figure 96: Dentists (per 1,000 Population), New Zealand, 2012-2018

Figure 97: Pharmacists (per 1,000 Population), New Zealand, 2012-2019

Figure 98: Nurses (per 1,000 Population), New Zealand, 2012-2018

Figure 99: Major Causes of Male Mortality (number of deaths), New Zealand, 2019

Figure 100: Major Causes of Mortality (number of deaths), New Zealand, 2019

Figure 101: Major Causes of Female Mortality (number of deaths), New Zealand, 2019

Figure 102: Disability-Adjusted Life Years by Major Disease (‘000), New Zealand, 2019

Figure 103: Healthcare Expenditure as Percentage of GDP (%), New Zealand, 2012-2019

Figure 104: Public-Private Share (%), New Zealand, 2012-2019

Figure 105: Opportunities and Challenges

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports